series-b
Stage
1
Investors
About
Voyager Therapeutics is a biotechnology company that develops gene therapies aimed at treating neurological diseases such as Alzheimer's, ALS, and Parkinson's by leveraging human genetics and novel delivery technologies across the blood-brain barrier.
Explore Voyager Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.